SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B1 - Prospectus [Rule 424(b)(1)]:
SEC Accession No. 0001104659-21-006683
Filing Date
2021-01-22
Accepted
2021-01-22 16:31:23
Documents
41

Document Format Files

Seq Description Document Type Size
1 424B1 tm2038048-9_424b1.htm 424B1 3561310
2 GRAPHIC lg_passage-4c.jpg GRAPHIC 54341
3 GRAPHIC tm2038048d4-tbl_ourpipe4c.jpg GRAPHIC 70796
4 GRAPHIC tm2038048d4-tbl_line4c.jpg GRAPHIC 128766
5 GRAPHIC tm2038048d1-lc_serum4clr.jpg GRAPHIC 208298
6 GRAPHIC tm2038048d1-lc_braincsf4clr.jpg GRAPHIC 116244
7 GRAPHIC tm2038048d1-lc_lunglive4clr.jpg GRAPHIC 191590
8 GRAPHIC tm2038048d1-lc_hexacti4clr.jpg GRAPHIC 96300
9 GRAPHIC tm2038048d1-lc_aveprint4clr.jpg GRAPHIC 127080
10 GRAPHIC tm2038048d1-lc_survi4clr.jpg GRAPHIC 102663
11 GRAPHIC tm2038048d1-lc_neuro4clr.jpg GRAPHIC 69851
12 GRAPHIC tm2038048d1-lc_day4clr.jpg GRAPHIC 154439
13 GRAPHIC tm2038048d1-bc_galact4clr.jpg GRAPHIC 133565
14 GRAPHIC tm2038048d1-lc_activ4clr.jpg GRAPHIC 110698
15 GRAPHIC tm2038048d1-lc_mice4clr.jpg GRAPHIC 203005
16 GRAPHIC tm2038048d1-lc_drgdegen4clr.jpg GRAPHIC 148613
17 GRAPHIC tm2038048d1-lc_median4clr.jpg GRAPHIC 142696
18 GRAPHIC tm2038048d4-fc_dsmbrev4c.jpg GRAPHIC 212888
19 GRAPHIC tm2038048d1-lc_aavmedi4clr.jpg GRAPHIC 86411
20 GRAPHIC tm2038048d1-ph_compar4clr.jpg GRAPHIC 201154
21 GRAPHIC tm2038048d1-ph_compar14clr.jpg GRAPHIC 61276
22 GRAPHIC tm2038048d1-lc_product4clr.jpg GRAPHIC 190552
23 GRAPHIC tm2038048d1-ph_ependy4clr.jpg GRAPHIC 76133
24 GRAPHIC tm2038048d1-lc_hummani4clr.jpg GRAPHIC 54541
25 GRAPHIC tm2038048d1-bc_thalamus4clr.jpg GRAPHIC 140247
26 GRAPHIC tm2038048d1-bc_thalamu14clr.jpg GRAPHIC 170815
27 GRAPHIC tm2038048d1-lc_snapampl4clr.jpg GRAPHIC 194519
28 GRAPHIC tm2038048d1-lc_protein4clr.jpg GRAPHIC 118367
29 GRAPHIC tm2038048d1-lc_curves4clr.jpg GRAPHIC 91868
30 GRAPHIC tm2038048d1-lc_pharma4clr.jpg GRAPHIC 119272
31 GRAPHIC tm2038048d1-lc_clinic4clr.jpg GRAPHIC 174134
32 GRAPHIC tm2038048d1-lc_compl4clr.jpg GRAPHIC 77546
33 GRAPHIC tm2038048d1-ph_sciat4clr.jpg GRAPHIC 146163
34 GRAPHIC tm2038048d1-lc_csfgalcbwlr.jpg GRAPHIC 61157
35 GRAPHIC tm2038048d1-lc_psych4clr.jpg GRAPHIC 89360
36 GRAPHIC tm2038048d1-lc_nerve4clr.jpg GRAPHIC 178270
37 GRAPHIC tm2038048d1-lc_baer4clr.jpg GRAPHIC 91222
38 GRAPHIC tm2038048d1-bc_histo4clr.jpg GRAPHIC 235182
39 GRAPHIC tm2038048d1-lc_bodyweig4clr.jpg GRAPHIC 153011
40 GRAPHIC tm2038048d1-lc_csfpleo4clr.jpg GRAPHIC 143688
41 GRAPHIC tm2038048d1-lc_snap4clr.jpg GRAPHIC 190498
  Complete submission text file 0001104659-21-006683.txt   10892689
Mailing Address TWO COMMERCE SQUARE 2001 MARKET STREET, 28TH FLOOR PHILADELPHIA PA 19103
Business Address TWO COMMERCE SQUARE 2001 MARKET STREET, 28TH FLOOR PHILADELPHIA PA 19103 2678660312
Passage BIO, Inc. (Filer) CIK: 0001787297 (see all company filings)

IRS No.: 822729751 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B1 | Act: 33 | File No.: 333-252213 | Film No.: 21546182
SIC: 2836 Biological Products, (No Diagnostic Substances)